Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Early Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Early Phase 1
1 (33.3%)Hypoactive Sexual Desire Disorder in Males
- First Posted Date
- 2019-06-28
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Mohit Khera
- Target Recruit Count
- 60
- Registration Number
- NCT04002661
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Testosterone for Penile Rehabilitation After Radical Prostatectomy
Early Phase 1
Terminated
- Conditions
- HypogonadismErectile Dysfunction
- Interventions
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2015-06-19
- Lead Sponsor
- Mohit Khera
- Target Recruit Count
- 3
- Registration Number
- NCT00848497
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
H-22411: BOTOX® for Peyronie's Disease
Phase 2
Completed
- Conditions
- Peyronie's Disease
- Interventions
- Other: Preservative free normal salineDrug: 100 units of Botulinum Toxin Type ADrug: 100 units Botulinum Toxin A
- First Posted Date
- 2008-12-22
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Mohit Khera
- Target Recruit Count
- 12
- Registration Number
- NCT00812838
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
News
No news found